- Conditions
- Painful Diabetic Neuropathy, Diabetic Neuropathy, Neuropathy
- Interventions
- Clonidine Hydrochloride Topical Gel, 0.1%, Clonidine Hydrochloride Gel Comparator
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 138 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 25
- States / cities
- Glendale, Arizona • Phoenix, Arizona • Anaheim, California + 20 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–21
of 21
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Pain, Low Back Pain
- Interventions
- BEMA Buprenorphine
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Marietta, Georgia
- Conditions
- Opioid Dependence
- Interventions
- BEMA Buprenorphine NX, Buprenorphine
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 55 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 2017
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • Orem, Utah • Salt Lake City, Utah
- Conditions
- Painful Diabetic Neuropathy, Diabetes
- Interventions
- clonidine hydrochloride topical gel, 0.1%
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 197 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 20
- States / cities
- Phoenix, Arizona • Santa Monica, California • Walnut Creek, California + 16 more
- Conditions
- Migraine Headache
- Interventions
- DFN-15 Active, DFN-15 Placebo
- Drug · Other
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 631 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 43
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 39 more
- Conditions
- Pain, Cancer
- Interventions
- BEMA Fentanyl
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 244 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Opioid-induced Constipation
- Interventions
- Naldemedine, Lubiprostone, Naloxegol
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 34,532 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2029
- U.S. locations
- 1
- States / cities
- Wilmington, Delaware
- Conditions
- Low Back Pain
- Interventions
- Buprenorphine, Placebo
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 815 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 66
- States / cities
- Birmingham, Alabama • Haleyville, Alabama • Mobile, Alabama + 57 more
- Conditions
- Back Pain Lower Back Chronic, Chronic Pain
- Interventions
- Buprenorphine Buccal Film [Belbuca], Urine Drug Screening, actigraph, PROMIS 29, sit to stand test, numerical rating scale pain score, patient global impression of function, PROMIS - sleep
- Drug · Other · Device + 1 more
- Lead sponsor
- Carolinas Pain Institute
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Dental Pain
- Interventions
- Oxycodone, Buprenorphine, Placebo Film, Placebo Capsule
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 153 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009
- U.S. locations
- 3
- States / cities
- Austin, Texas • San Marcos, Texas • Salt Lake City, Utah
- Conditions
- Pain, Cancer
- Interventions
- BEMA™, Placebo
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 152 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Wilmington, North Carolina
- Conditions
- Low Back Pain
- Interventions
- Buprenorphine, Placebo
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 752 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 60
- States / cities
- Mobile, Alabama • Phoenix, Arizona • Anaheim, California + 51 more
- Conditions
- Pain, Low Back Pain
- Interventions
- Buprenorphine, Placebo
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 334 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 24
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 21 more
- Conditions
- Painful Diabetic Neuropathy, Diabetic Neuropathy, Neuropathy
- Interventions
- Clonidine Gel 0.1%, Placebo
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 260 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 23
- States / cities
- Phoenix, Arizona • Santa Monica, California • Walnut Creek, California + 20 more
- Conditions
- Opioid Dependence
- Interventions
- Buprenorphine and naloxone
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 65 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 2017
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Pain, Low Back Pain, Osteoarthritis, Neuropathic Pain
- Interventions
- BEMA Buprenorphine
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 302 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 26
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 23 more
- Conditions
- Pain
- Interventions
- Buprenorphine, Placebo film, Oxycodone, Morphine sulfate, Placebo capsule
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 3
- States / cities
- Overland Park, Kansas • Philadelphia, Pennsylvania • Salt Lake City, Utah
- Conditions
- Opioid Dependence
- Interventions
- BEMA Buprenorphine NX films
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 249 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 10
- States / cities
- Birmingham, Alabama • Haleyville, Alabama • Jacksonville, Florida + 7 more
- Conditions
- Respiratory Depression
- Interventions
- Belbuca 300 µg, Belbuca 600 µg, Belbuca 900 µg, Oxycodone 30 mg, Oxycodone 60 mg, Placebo
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Migraine Headache
- Interventions
- DFN-15 Active, DFN-15 Placebo
- Drug · Other
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 622 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 45
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 42 more
- Conditions
- Low Back Pain, Osteoarthritis, Neuropathic Pain
- Interventions
- EN3409
- Drug
- Lead sponsor
- BioDelivery Sciences International
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 304 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 57
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 52 more